Literature DB >> 3100625

Target cell recognition structures in LDCC and ODCC.

K C Gorman, K P Kane, W R Clark.   

Abstract

Cytotoxic T lymphocyte effector cells specific for a defined class I antigen can kill target cells displaying a wide range of different class I proteins in the presence of certain lectins and oxidizing agents. However, optimal lysis of the target cell (TC) still requires interaction of the CTL with the TC class I proteins. This raises the question of how the lectin or oxidizing agent alters the system in such a way that an "inappropriate" CTL-TC interaction takes place, in a class I-dependent manner. In this study we show that if papain-sensitive molecules are cleared from the TC surface and are allowed to regenerate in the presence of tunicamycin, the cells still serve as targets in direct, class I antigen-specific CTL killing, but not in LDCC or ODCC. Target cells treated in this way display N-linked carbohydrate-less class I proteins, and presumably other N-linked carbohydrate-less, papain-sensitive molecules as well. We present data showing that both types of molecules are important in nonspecific lytic reactions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3100625

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Clonal analysis of liver-derived T cells of patients with primary biliary cirrhosis.

Authors:  R M Hoffmann; G R Pape; U Spengler; E P Rieber; J Eisenburg; J Döhrmann; G Paumgartner; G Riethmüller
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

2.  Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus.

Authors:  M D Lindsley; R Thiemann; M Rodriguez
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  Defective mitogen-induced cellular cytotoxicity in untreated patients with active rheumatoid arthritis.

Authors:  G Vaiopoulos; D Kyriakou; H Papadaki; P Kaklamanis; G D Eliopoulos
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.